Here is Why Growth Investors Should Buy Palomar (PLMR) Now

Zacks identifies Palomar (PLMR) as a potential growth stock, citing a Growth Score of B and Zacks Rank #2 (Buy). It reports projected EPS growth of 28.9% this year versus a 5% industry average, year-over-year cash flow growth of 68.1% versus 20.7% for the industry, and a 1% rise in the current-year consensus earnings estimate over the past month.

Analysis

The central issue is earnings quality, not the growth score. For an insurer, reported cash-flow growth can move sharply with premium collection, claims payments, and reserve timing; it is not equivalent to recurring free cash flow available for expansion. The cited 28.9% EPS outlook therefore matters only if underwriting results support it. Verify premium growth alongside rate, retention, loss and expense ratios, reserve development, and catastrophe losses before treating the projection as durable.

The asymmetry in the article is notable: a 1% upward consensus revision over a month is modest relative to the projected EPS growth, leaving the thesis vulnerable if estimates stop rising. Near term, promotional coverage may support sentiment, but it is not an independent earnings catalyst. Over 1–3 months, results and guidance should establish whether growth is coming from profitable underwriting or from exposure growth that raises future loss volatility. Over 6–18 months, catastrophe severity, reinsurance pricing/availability, and reserve adequacy can overwhelm recent growth rates. Specialty insurers may benefit if pricing remains firm, while competitors could gain share if Palomar reins in risk; the article provides no evidence to establish either outcome.

Contrarian read: the growth case may be directionally right, but the article’s metrics do not demonstrate a margin of safety or justify paying any valuation. No valuation, catastrophe exposure, or underwriting data are provided. Treat PLMR as a diligence/watch-list name rather than an automatic buy; falsify the thesis on weakening underwriting ratios, adverse reserve development, or a reversal in consensus estimates.

Key Decisions for Investors

• Do not chase the promotional growth framing on these data alone. Before initiating or adding to PLMR, verify current valuation, premium growth, loss and expense ratios, reserve development, catastrophe exposure, and reinsurance terms.
• Watch the next earnings release and guidance for confirmation that EPS growth is supported by underwriting profitability, not just premium expansion or cash-flow timing. Reassess if consensus estimates turn downward or management lowers its outlook.
• If already long, size the position for specialty-insurance and catastrophe volatility; a deterioration in underwriting metrics or adverse reserve development is a thesis trigger to reduce exposure. No high-conviction pair or options trade is supported by the supplied information.